The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin
- 31 December 1985
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 24, 29-43
- https://doi.org/10.1016/0065-2571(85)90068-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agentAntimicrobial Agents and Chemotherapy, 1983
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Ribavirin Treatment of Experimental Respiratory Syncytial Viral InfectionPublished by American Medical Association (AMA) ,1983
- Synthesis and antitumor activity of 2-.beta.-D-ribofuranosylselenazole-4-carboxamide and related derivativesJournal of Medicinal Chemistry, 1983
- Clinical Efficacy of Ribavirin in the Treatment of Genital Herpes simplex Virus InfectionChemotherapy, 1981
- Amantadine and ribavirin aerosol treatment of influenza A and B infection in miceAntimicrobial Agents and Chemotherapy, 1980
- Synthesis and antiviral activity of certain thiazole C-nucleosidesJournal of Medicinal Chemistry, 1977
- Studies on bredinin. I. Isolation, characterization and biological properties.The Journal of Antibiotics, 1974
- Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosidesJournal of Medicinal Chemistry, 1972
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972